NCT00248092View on ClinicalTrials.gov

Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

May 31, 2006

Conditions
Attention Deficit Disorder With HyperactivityAmphetamine-Related DisordersSubstance-Related Disorders
Interventions
DRUG

NRP104

Trial Locations (1)

21224

Johns Hopkins Bayview Medical Center, Clinical Studies Program, Baltimore

Sponsors
All Listed Sponsors
lead

New River Pharmaceuticals

INDUSTRY

NCT00248092 - Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse | Biotech Hunter | Biotech Hunter